P. W. Tuke

1.3k total citations
15 papers, 815 citations indexed

About

P. W. Tuke is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, P. W. Tuke has authored 15 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Immunology and 5 papers in Oncology. Recurrent topics in P. W. Tuke's work include T-cell and Retrovirus Studies (7 papers), Viral-associated cancers and disorders (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). P. W. Tuke is often cited by papers focused on T-cell and Retrovirus Studies (7 papers), Viral-associated cancers and disorders (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). P. W. Tuke collaborates with scholars based in United Kingdom, France and Maldives. P. W. Tuke's co-authors include Jeremy A. Garson, Hervé Perron, F. Besème, F. Bedin, J. M. Seigneurin, Bernard Mandrand, François Mallet, Gláucia Paranhos‐Baccalà, Jean-Luc Blond and Cécile Voisset and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of General Virology and British Journal of Haematology.

In The Last Decade

P. W. Tuke

15 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. W. Tuke United Kingdom 12 255 249 241 237 144 15 815
Anné Møller-Larsen Denmark 21 443 1.7× 329 1.3× 297 1.2× 307 1.3× 16 0.1× 49 1.1k
Renée N. Douville Canada 16 354 1.4× 329 1.3× 505 2.1× 119 0.5× 14 0.1× 32 1.1k
Catherine Legras‐Lachuer France 20 158 0.6× 30 0.1× 348 1.4× 294 1.2× 99 0.7× 42 994
Oya Cingöz United States 12 297 1.2× 69 0.3× 274 1.1× 147 0.6× 11 0.1× 18 842
R. Emanoil‐Ravier France 14 140 0.5× 58 0.2× 242 1.0× 110 0.5× 7 0.0× 40 713
Ti‐Chun Chao United States 10 192 0.8× 35 0.1× 723 3.0× 270 1.1× 98 0.7× 12 1.1k
F. Bedin France 13 278 1.1× 529 2.1× 523 2.2× 152 0.6× 10 0.1× 21 1.1k
Hidetoshi Ikeda Japan 16 70 0.3× 27 0.1× 83 0.3× 178 0.8× 37 0.3× 38 754
Stéphanie Eyquem France 7 276 1.1× 119 0.5× 575 2.4× 65 0.3× 15 0.1× 8 939
Eiko Nishiuchi United States 10 85 0.3× 33 0.1× 665 2.8× 170 0.7× 194 1.3× 11 1.0k

Countries citing papers authored by P. W. Tuke

Since Specialization
Citations

This map shows the geographic impact of P. W. Tuke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. W. Tuke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. W. Tuke more than expected).

Fields of papers citing papers by P. W. Tuke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. W. Tuke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. W. Tuke. The network helps show where P. W. Tuke may publish in the future.

Co-authorship network of co-authors of P. W. Tuke

This figure shows the co-authorship network connecting the top 25 collaborators of P. W. Tuke. A scholar is included among the top collaborators of P. W. Tuke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. W. Tuke. P. W. Tuke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Patel, Poorvi, P. W. Tuke, Kate I. Tettmar, et al.. (2015). No evidence of transfusion transmission of Adenovirus and Epstein–Barr virus infections in paediatric recipients post–bone marrow transplant. Vox Sanguinis. 109(1). 95–97. 2 indexed citations
2.
Tettmar, Kate I., P. W. Tuke, Sam Lattimore, et al.. (2015). Consequences of screening English blood donors for HHV‐8 antibodies. Is it worth it?. ISBT Science Series. 11(1). 32–37. 1 indexed citations
3.
Tedder, Richard S., et al.. (2012). Therapy‐induced clearance of HCV core antigen from plasma predicts an end of treatment viral response. Journal of Viral Hepatitis. 20(1). 65–71. 26 indexed citations
4.
Paul, Joel, P. W. Tuke, Sally Hargreaves, et al.. (2011). Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma?. International Journal of STD & AIDS. 22(10). 585–589. 9 indexed citations
5.
Tuke, P. W., R.P. Parry, & Hazel Appleton. (2009). Parvovirus PARV4 visualization and detection. Journal of General Virology. 91(2). 541–544. 15 indexed citations
6.
Tuke, P. W., S Hawke, Paul Griffiths, & Duncan A. Clark. (2004). Distribution and quantification of human herpesvirus 6 in multiple sclerosis and control brains. Multiple Sclerosis Journal. 10(4). 355–359. 17 indexed citations
7.
Gaudin, Philippe, Samreen Ijaz, P. W. Tuke, et al.. (2000). Infrequency of detection of particle‐associated MSRV/HERV‐W RNA in the synovial fluid of patients with rheumatoid arthritis. Lara D. Veeken. 39(9). 950–954. 20 indexed citations
8.
Andrews, William D., P. W. Tuke, Ammar Al‐Chalabi, et al.. (2000). Detection of reverse transcriptase activity in the serum of patients with motor neurone disease. Journal of Medical Virology. 61(4). 527–532. 54 indexed citations
9.
Perron, Hervé, Jeremy A. Garson, F. Bedin, et al.. (1997). Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proceedings of the National Academy of Sciences. 94(14). 7583–7588. 384 indexed citations
10.
Tuke, P. W., Hervé Perron, F. Bedin, F. Besème, & Jeremy A. Garson. (1997). Development of a pan-retrovirus detection system for multiple sclerosis studies. Acta Neurologica Scandinavica. 95. 16–21. 36 indexed citations
11.
Perron, Hervé, P. W. Tuke, Jeremy A. Garson, et al.. (1997). Cell cultures and associated retroviruses in multiple sclerosis. Acta Neurologica Scandinavica. 95. 22–31. 25 indexed citations
12.
Brennan, Matt, J. A. J. Barbara, M. Contreras, et al.. (1993). Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.. BMJ. 307(6914). 1235–1239. 45 indexed citations
13.
Tuke, P. W., et al.. (1992). Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of ‘nested’ PCR products. Journal of Virological Methods. 40(2). 163–173. 60 indexed citations
14.
Brillanti, S., Jeremy A. Garson, P. W. Tuke, et al.. (1991). Effect of α‐interferon therapy on hepatitis C viraemia in community‐acquired chronic non‐A, non‐B hepatitis: A quantitative polymerase chain reaction study. Journal of Medical Virology. 34(2). 136–141. 75 indexed citations
15.
Tedder, Richard S., Moya Briggs, C. Ring, et al.. (1991). Hepatitis C antibody profile and viraemia prevalence in adults with severe haemophilia. British Journal of Haematology. 79(3). 512–515. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026